Pfizer Stock Falls 1.04% to $26.58 Despite Positive Drug Trial Results and Cost-Cutting Plan
Pfizer shares moved lower in the latest trading session as investors weighed encouraging clinical trial progress against broader market weakness affecting healthcare stocks. The pharmaceutical giantâs stock closed at $26.58,…







